Mehawej Jordy, Saczynski Jane, Gurwitz Jerry H, Abu Hawa O, Bamgbade Benita A, Wang Wei-Jia, Paul Tenes, Trymbulak Katherine, Saleeba Connor, Wang Zi-Yue, Kiefe Catarina I, Goldberg Robert J, McManus David D
Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Northeastern University, Boston, MA, USA.
J Geriatr Cardiol. 2020 Aug;17(8):502-509. doi: 10.11909/j.issn.1671-5411.2020.08.004.
Though engaging patients with atrial fibrillation (AF) in understanding their stroke risk is encouraged by guidelines, little is known regarding AF patients' perceived stroke risk or its relationship with oral anticoagulation (OAC) use. We aim to identify factors associated with underestimation of stroke risk among older patients with AF and relate this to OAC use.
Data are from the ongoing SAGE (Systematic Assessment of Geriatric Elements)-AF study, which included older patients (> 65 years) with non-valvular AF and a CHADS-VASc score of ≥ 2. Participants reported their perceived risk of having a stroke without OAC. We compared the perceived risk to CHADS-VASc predicted stroke risk and classified participants as "over" or "under" estimators, and identified factors associated with underestimation of risk using multiple logistic regression.
The average CHADS-VASc score of 915 participants (average age: 75 years, 47% female, 86% white) was 4.3 ± 1.6, 43% of participants had discordant predicted and self-reported stroke risks. Among the 376 participants at highest risk (CHADS-VASc score ≥ 5), 46% of participants underestimated their risk. Older participants (≥ 85 years) were more likely and OAC treated patients less likely to underestimate their risk of developing a future stroke than respective comparison groups.
A significant proportion of study participants misperceived their stroke risk, mostly by overestimating. Almost half of participants at high risk of stroke underestimated their risk, with older patients more likely to do so. Patients on OAC were less likely to underestimate their risk, suggesting that successful efforts to educate patients about their stroke risk may influence treatment choices.
尽管指南鼓励房颤(AF)患者了解其卒中风险,但对于房颤患者感知到的卒中风险或其与口服抗凝药(OAC)使用之间的关系知之甚少。我们旨在确定老年房颤患者中与低估卒中风险相关的因素,并将其与OAC的使用联系起来。
数据来自正在进行的SAGE(老年因素系统评估)-AF研究,该研究纳入了年龄大于65岁的非瓣膜性房颤患者且CHADS-VASc评分≥2。参与者报告了他们在未使用OAC情况下感知到的卒中风险。我们将感知到的风险与CHADS-VASc预测的卒中风险进行比较,并将参与者分类为“高估”或“低估”者,使用多因素逻辑回归确定与风险低估相关的因素。
915名参与者(平均年龄:75岁,47%为女性,86%为白人)的平均CHADS-VASc评分为4.3±1.6,43%的参与者预测的和自我报告的卒中风险不一致。在376名风险最高(CHADS-VASc评分≥5)的参与者中,46%的参与者低估了他们的风险。与各自的对照组相比,年龄较大(≥85岁)的参与者更有可能低估未来发生卒中的风险,而接受OAC治疗 的患者则不太可能低估。
很大一部分研究参与者错误地感知了他们的卒中风险,主要是高估。几乎一半的高卒中风险参与者低估了他们的风险,年龄较大的患者更有可能如此。接受OAC治疗的患者低估风险的可能性较小,这表明成功地对患者进行卒中风险教育可能会影响治疗选择。